Advertisement

Topics

Companies Related to "Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients" [Most Relevant Company Matches] RSS

03:41 EDT 21st May 2018 | BioPortfolio

Here are the most relevant search results for "Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients" found in our extensive corporate database of over 50,000 company records.

Showing "Prophylactic Therapy Cytomegalovirus Liver Transplant Recipients" Companies 1–25 of 1,300+

Relevant

Inspiration Biopharmaceuticals

Inspiration Biopharmaceuticals was founded in 2004 with the mission to revolutionize treatments for hemophilia. The Company is focused on developing products that have the potential to broaden patient access to therapy, including prophylactic use. Greater access and more frequent prophylactic therapy have been shown to reduce complications of the disease and enhance patients' long-term health and ...


Transplant Genomics Inc.

Transplant Genomics is a molecular diagnostics company committed to improving organ transplant outcomes. Working with the transplant community, TGI will bring vital advances in diagnosis and prediction of transplant status from bench to clinic, supporting clinicians with clear, actionable information to optimize immunosuppression therapy, enhance patient c...

Vesta Therapeutics, Inc

Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, huma...


Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

American Liver Foundation

The American Liver Foundation is the nation’s largest non-profit organization focused solely on promoting liver health and disease prevention. The mission of the American Liver Foundation is to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Texas Children's Hospital

Texas Children's Hospital runs an active transplantation program in heart, lungs, liver, kidney and bone morrow for pediatric patients. In 1984, Dr. Denton A. Cooley performed the first pediatric heart transplant on a 9-month-old female patient. She lived to be 13 years old. Since that time, the heart transplant program has grown into one of the largest and most successful program of its kind in t...

Arbios Systems, Inc.

Arbios Systems, Inc. is developing proprietary medical devices and cell-based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,” and the H...

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cancers related to oncogenic viruses. The Company’s lead cell product, CytovirTM CMV, for the treatment and prevention of cytomegalovirus (CMV) infections in patients following al...

MOLOGEN AG

MOLOGEN is specializing in selected areas of Molecular Medicine. Our areas of competence are gene expression, gene therapy and bioinformatics. We are dedicated to the development of DNA expression and delivery technologies for human and veterinary applications, leading to products for gene therapy, and prophylactic and therapeutic DNA-based vaccines

Sirtex Medical Inc.

Sirtex Medical Limited (ASX:SRX) is an Australian-based global healthcare business working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 50,000 doses have been supplied to treat patients with liver cancer at more than 800 medical...

Guidry & East

Welcome! Thank you for visiting Guidry & East's website. We offer expert consulting services to Transplant Centers to bring efficiency, improve financial results, and enhance quality patient care.Our consulting team has collectively over 150 years of Clinical Transplant experience and includes experienced Transplant Administrators who have been responsible for gross revenues of over $200 million. ...

Cytonet GmbH & Co. KG

"Cytonet provides successful solutions to heal life-threatening diseases by using pharmaceuticals based on human cells while using the competence in cell-therapy to extend the world-wide leading position in in vitro and in vivo therapy of heaviest disease of vital parts, especially the liver."

Leonard Hair Transplant Associates

Leonard Hair Transplant Associates offers the latest technology in hair restoration surgery and medical treatments, customized to meet individual patient hair restoration needs, including Hair Transplantation, NeoGraft™ Automated Follicular Unit Extraction Hair Transplantation, Low-Level Laser Therapy, PROPECIA® and ROGAINE® FOAM. With offices i...

SangStat Medical Corporation

SangStat, The Transplant Company(R), is a specialty pharmaceutical company applying a disease management approach to improve the outcome of organ transplantation. The Company's devices, drugs and services form a family of products that address the needs of patients in each stage of transplant care from pre-transplant monitoring to lifetime post-transplant care. SangStat's product pipeline is a com...

PaulPearsall.com

Over 200 professional journals and articles. Most recent journal article: "Changes in Heart Transplant Recipients that Parallel the Personalities of Their Donors. Journal of Near-Death Studies, January, 2002. 48 research presentations published in medical and scientific meeting proceedings Author of 15 international best-selling books. Most recent book: The Beethoven Factor: The New Positive Psych...

Transplant Connect

Transplant Connect is an innovative medical software firm that specializes in electronic medical record and clinical information systems for the organ, tissue and eye transplant field. It was founded in 2003, with the mission of improving and increasing transplantation through modern software and communications. The iTransplantSM Platform is a web-centr...

Cromwell Hospital

The Cromwell Hospital in London provides healthcare facilities for UK and overseas patients. Major specialities include cancer treatment, liver disease and transplant, neurosurgery, spinal surgery, heart surgery, gamma knife surgery (radiosurgery), paediatric care, craniofacial surgery and urology.

YES

YES is a grassroots organization that provides cancer patients with support, resources, options, education and hope in their fight against liver tumors. It is made up of survivors who have undergone treatment for primary hepatocellular (liver) cancer or liver metastases (cancer that has spread to the liver) from other cancers. For more information ...

AlphaNet, Inc.

Alpha-1 Antitrypsin Deficiency is one of North America’s most prevalent, potentially lethal hereditary disorders. Discovered in 1963, Alpha-1 can cause life-threatening lung and/or liver disease. It is a leading genetic killer of adults in North America and a leading cause of liver transplants in children. It is estimated that between 10,000 and 15,000 ...

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. By creating a platform focused on critical areas of transplant medicine, Magenta Therapeutics is pioneering an integrated approach to extend the curative power of bone mar...

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treatment of individuals with inhibitor complications. Inspiration has a broad development portfolio, which includes advanced, clinical-stage product candidates for the treatment of hemophilia A and hemop...

Osteotech

Osteotech, Inc. is a global leader in the processing of human bone and connective tissue for transplantation and an innovator in the development, manufacturing and marketing of biologic, biomaterial and device systems for musculoskeletal surgery. With a particular focus on spinal, trauma, and total joint revision procedures, the Company's current and development-stage technologies address needs wi...

Methodist Health System

The Transplant Institute at Methodist Dallas Medical Center has performed more than 2,500 transplants since its founding in 1981. The Institute made medical history in 1992 when it performed the world's first successful simultaneous heart-kidney-pancreas transplant. Since that time, Methodist Dallas Medical Center Transplant Center has performed three of the world's five combined simultaneous hear...

Ars Arthro AG

The autologous cartilage transplant CaReSâ„¢ - Cartilage Repair System - offered by ARS ARTHRO AG is a 3D mechanically stable transplant based on patientspecific autologous cartilage cellls and a unique patent pending collagen matrix.Based on the present state of art, the Ars Arthro transplant is the only product with all of the following characteristics: easily adaptable intraoperatively to f...

On Lok, Inc.

On Lok pioneered the PACE model of care more than 37 years ago; this model has since been replicated at 72 programs in 31 states. On Lok and other PACE sites provide frail seniors with the necessary primary and preventive care, nutrition, prescription drugs, physical therapy, social services and other acute and long-term care participants need in order to live at home rather than in a nursing faci...


More From BioPortfolio on "Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks